At Epiloid, we are dedicated to improving the quality of neurological drug testing. Using 3D human cerebral organoid assays, we evaluate drug efficacy prior to clinical trials in order to reduce the staggering costs, waste, and inaccuracies of animal testing. This technology allows us to assess and record cerebral responses to induced neurological diseases – such as Epilepsy and Parkinson’s – which provides more accurate insight into patient responses during clinical trials.
Housed in Downtown Toronto, Epiloid is at the core of neurological innovation. Visit our website below for more information and sign up for our email updates!
Company Details
- Employees
- 8
- Founded
- 2022
- Address
- The Ethical Challenges They Bring.
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.epiloid.com
Epiloid Biotechnology Questions
Epiloid Biotechnology's website is http://www.epiloid.com
Epiloid Biotechnology's LinkedIn profile is https://www.linkedin.com/company/epiloid-biotechnology
Epiloid Biotechnology has
8 employees.
View email and phone details for 8
employees at Epiloid Biotechnology.
Epiloid Biotechnology's industry is
Biotechnology Research
Epiloid Biotechnology's top competitors are
Mesintel Therapeutics,
Telescope Therapeutics,
Feldan Therapeutics ǀ Feldan Thérapeutiques,
Mesosil,
Bough Biosciences,
Noa Therapeutics,
Axolotl Biosciences,
Inteligex,
Proteinqure,
Mediphage.
Epiloid Biotechnology's categories are Biotechnology Research
Epiloid Biotechnology's founding year is 2022
